Clinical Trials
20
Active:0
Completed:13
Trial Phases
3 Phases
Phase 1:2
Phase 4:1
Not Applicable:14
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (17 trials with phase data)• Click on a phase to view related trials
Not Applicable
14 (82.4%)Phase 1
2 (11.8%)Phase 4
1 (5.9%)The Sakakibara Health Integrative Profile of Atherosclerotic-Carcinogenesis Hypothesis (SHIP-AC)
Completed
- Conditions
- Atheroscleroses, CoronaryAtherosclerosis of ArteryCancers
- First Posted Date
- 2019-12-13
- Last Posted Date
- 2019-12-18
- Lead Sponsor
- Sakakibara Heart Institute
- Target Recruit Count
- 8856
- Registration Number
- NCT04198896
Japanese OMI Treatment With Kit-positive Cells for Enhanced Regeneration
Phase 1
- Conditions
- Chronic Heart FailureOld Myocardial Infarction
- First Posted Date
- 2017-11-22
- Last Posted Date
- 2021-03-18
- Lead Sponsor
- Sakakibara Heart Institute
- Target Recruit Count
- 6
- Registration Number
- NCT03351400
- Locations
- 🇯🇵
Sakakibara Heart Institute, Tokyo, Japan
Pathogenic Mechanisms of Cancer and Cardiovascular Diseases
Completed
- Conditions
- CancerPathogenesisCardiovascular Diseases
- First Posted Date
- 2017-02-13
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- Sakakibara Heart Institute
- Target Recruit Count
- 66
- Registration Number
- NCT03051191
- Locations
- 🇯🇵
Sakakibara Heart Institute, Fuchu, Japan
🇯🇵The Cancer Institute Hospital for Japanese Foundation for Cancer Research, Tokyo, Japan
The Sakakibara Health Integrative Profile Cohort Study
Completed
- Conditions
- Cancer
- First Posted Date
- 2016-12-29
- Last Posted Date
- 2016-12-30
- Lead Sponsor
- Sakakibara Heart Institute
- Target Recruit Count
- 32095
- Registration Number
- NCT03005834
News
No news found